S

scPharmaceuticals
D

SCPH

3.75000
USD
0.15
(4.17%)
Market Closed
Volume
7,964
EPS
-2
Div Yield
-
P/E
-2
Market Cap
187,650,503
News

Title: scPharmaceuticals

Sector: Healthcare
Industry: Biotechnology
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.